Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

AirSculpt Technologies, Inc. remains a Buy after a 70% stock decline, due to attractive valuation and recent buying volume. AIRS faces near-term revenue softness and must balance cost-cutting with growth initiatives, especially targeting profitable GLP-1 user segments. The company's high average ticket price (~$14k) and lack of a clear moat raise questions about long-term scalability amid inflation risks.

SAN DIEGO, March 18, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of AirSculpt Technologies, Inc. (NASDAQ: AIRS). The investigation focuses on AirSculpt Technologies executive officers and whether investor losses may be recovered under federal securities laws.

Preliminary Fiscal Year 2025 Revenue of $151.8 Million Refreshed Marketing Strategy Delivers Positive Same-Store Sales in February 2026 Strong Balance Sheet and Enhanced Liquidity MIAMI BEACH, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) (“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced that it expects to file a Form 12b-25 with the U.S. Securities and Exchange Commission (the “SEC”) on or about March 16, 2026, providing the Company a 15-day extension to file its annual report for the fiscal year ended December 31, 2025 on Form 10-K (the “Annual Report”).

MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced the appointment of Mike Doyle as the Non-Executive Chairman of its Board of Directors.

AirSculpt Technologies, Inc. ( AIRS ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Yogesh Jashnani - CEO & Director Dennis Dean - Chief Financial Officer Conference Call Participants Allison Malkin - ICR Inc. Marco Criscuolo - Nephron Research LLC Sam Eiber - BTIG, LLC, Research Division Presentation Operator Good morning, ladies and gentlemen and welcome to the AirSculpt Technologies, Inc. Third Quarter 2025 Earnings Call. [Operator Instructions] Please note that this event is being recorded.

AirSculpt Technologies, Inc. (AIRS) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.02 per share a year ago.

MIAMI BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the third quarter ended September 30, 2025.